Market Snapshot
S&P Futures
3,809.5
Dow Futures
30,868
Nasdaq Futures
11,633.25
Acasti Pharma Inc. (ACST) stock declined over -1.02% intraday to trade at $0.86 a share on NASDAQ. The stock opened with a loss of -2.27% at $0.85 and touched an intraday high of $0.878, falling -1.15% against the last close of $0.87. The stock went to a low of $0.821 during the session.
Prev. Close
Market Cap
Day Low
Open
Number of Shares
Day High
P/E ratio
EPS (TTM)
Cash Flow per Share
Free Float in %
Book Value
Volume
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
2022-06-30 | $0.85 | $0.878 | $0.821 | $0.858 | 86,740 |
2022-06-29 | $0.88 | $0.88 | $0.85 | $0.87 | 62,300 |
2022-06-28 | $0.89 | $0.91 | $0.87 | $0.87 | 65,800 |
2022-06-27 | $0.91 | $0.92 | $0.89 | $0.92 | 77,300 |
2022-06-24 | $0.93 | $0.93 | $0.9 | $0.91 | 94,600 |
2022-06-23 | $0.91 | $0.93 | $0.89 | $0.93 | 90,700 |
2022-06-22 | $0.9 | $0.91 | $0.9 | $0.9 | 82,800 |
2022-06-21 | $0.96 | $0.96 | $0.88 | $0.93 | 170,300 |
2022-06-17 | $0.89 | $0.96 | $0.88 | $0.93 | 82,700 |
2022-06-16 | $0.95 | $0.95 | $0.88 | $0.9 | 109,800 |
Employees-
Beta1.39
Sales or Revenue115 Thousands
5Y Sales Change-
Fiscal Year Ends2021-03-30
SectorHealth Care
IndustryPharmaceuticals
Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre, an omega-3 phospholipid therapeutic to treat patients with hypertriglyceridemia. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Acasti Pharma Inc. (NASDAQ: ACST) stock price is $0.86 as of the last check on Thursday, June 30. During the trading session, ACST stock reached the peak price of $0.878 while $0.821 was the lowest point it dropped to.
The NASDAQ listed ACST is part of Pharmaceuticals industry that operates in the broader Health Care sector. Acasti Pharma Inc. , a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases.
Ms. Janelle D'Alvise
Pres, CEO, Corp. Sec. & Director
Dr. Pierre Lemieux M.D., Ph.D.
Co-Founder, COO & Chief Scientific Officer
Mr. Brian D. Ford CPA, CA
Chief Financial Officer
Dr. Yves Lachance Ph.D.
VP of Quality & Compliance
ACST stock traded closed the last session at $0.858, which is $-0.01 or -1.02% lower than its previous close of $0.87. ACST's current trading price is 4.62% lower than its 52-week high of $5.04 where as its distance from 52-week low of 0.82% is -82.98%.
Number of ACST employees currently stands at -. ACST operates from 3009 boulevard de la Concorde East, Suite 102, Laval, QC H7E 2B5, Canada.
Official Webiste of $ACST is: https://www.acastipharma.com
ACST could be contacted at ACST operates from 3009 boulevard de la Concorde East, Suite 102, Laval, QC H7E 2B5, Canada, or at phone # and can also be accessed through its website.
ACST stock volume for the day was 86,830 shares while in the previous session number of ACST shares traded was 86,740 . The average number of ACST shares traded daily for last 3 months was 114.84 Thousands.
The percentage change in ACST stock occurred in the recent session was -1.02% while the dollar amount for the price change in ACST stock was $-0.01.
In the recent session, the day high for ACST stock was $0.878 while the low for ACST stock touched on the day was $0.821.
The market value of ACST currently stands at 49.87 Million with its latest stock price at $0.86 and 36.84 Million of its shares outstanding.